Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension

7680679870017 CH-67987 Pulver
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1 + 1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
24/09/2025
Summary of Product Characteristics
Français
24/09/2025
Summary of Product Characteristics
Italien
24/09/2025

Detailed composition

Substance Quantity Type Category
PUL
50.0 UG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
SUSR
50.0 UG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
PUL
- Substance HNIDK
SUSR
- Substance HNIDK
PUL
- Substance HNIDK
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
PUL
- Substance HNIDK
PUL
- Substance HNIDK
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
- Substance HNIDK
SOLV
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
- Substance HNIDK
SUSR
1.77 MG Substance HBESI
SUSR
0.18 MG Substance HBESI

Reimbursement information

Public price
CHF 166.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2022

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
67987
Drug name
Shingrix, Pulver und Suspension zur Herstellung einer Injektionssuspension
Galenic form
PULVS
ATC Code
J07BK03
Authorization status
Z
Dispensing category
B
First authorization
07/10/2021
Authorization expiration date
06/10/2026
IT Number
08.08.
Domain
Human medicine
Field of application
Prävention von Herpes Zoster

Package details

Description (FR)
SHINGRIX subst sèche c solv (susp) flac 0.5 ml
Description (DE)
SHINGRIX Trockensub c Solv (Susp) Durchstf 0.5 ml
Market launch
07/10/2021
Narcotic (BTM)
No

Other package sizes (1)

SHINGRIX subst sèche c solv (susp) 10 x 0.5 ml
10 + 10 DUR
GTIN: 7680679870024
View